Human Laboratory Study of Varenicline for Alcohol Use Disorder
Status:
Completed
Trial end date:
2018-07-07
Target enrollment:
Participant gender:
Summary
This study is a double-blind, randomized, placebo-controlled, parallel group, two-site study
designed to assess the effects of varenicline as compared with placebo on responses to in
vivo alcohol cue exposure in the human laboratory setting.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)